Drug targets cellular enzyme.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001550:Benzamidines / Q000494:pharmacology*; D004195:Disease Models, Animal; D004352:Drug Resistance, Microbial; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D007111:Immunity, Cellular / Q000187:drug effects*; D051379:Mice; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*; D012680:Sensitivity and Specificity
C074761:3,4,5-trihydroxybenzamidoxime; D019380:Anti-HIV Agents; D001550:Benzamidines; D006877:Hydroxamic Acids; D012264:Ribonucleotide Reductases; C035419:3,4-dihydroxybenzohydroxamic acid